CLOZAPINE Side Effects

7023685-2 | Neuroleptic Malignant Syndrome, Renal Failure Acute
on Sep 16, 2010 Male patient from GERMANY , 91 years of age, weighting 165.3 lb, was diagnosed with schizophrenia and was treated with Clozapine (View Usage). Patient experienced the following unwanted or unexpected effects: neuroleptic malignant syndrome, renal failure acute. Clozapine dosage: 1-0-1-3. During the same period patient was treated with NEUROCIL /00038602/ (Daily Dose: 400 Mg Milligram(s) Every Day) (View Neurocil /00038602/ Review and Neurocil /00038602/ Label ), CITALOPRAM HYDROBROMIDE (1-0.5-0) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), AMISULPRIDE (Daily Dose: 800 Mg Milligram(s) Every Day) (View Amisulpride Review and Amisulpride Label ). Patient was hospitalized.

7021072-4 | Grand Mal Convulsion, Myoclonus, Speech Disorder
Patient was taking Clozapine (View Usage). Patient had the following side effects: grand mal convulsion, myoclonus, speech disorder on Sep 15, 2010 from SPAIN Additional patient health information: Male patient , 15 years of age, was diagnosed with schizophrenia and. Clozapine dosage: . During the same period patient was treated with CLOMIPRAMINE (View Clomipramine Review and Clomipramine Label ).

7021071-2 | Grand Mal Convulsion, Myoclonus, Speech Disorder
Adverse event was reported on Sep 15, 2010 by a Male patient taking Clozapine (View Usage) (Dosage: ) was diagnosed with schizophrenia and. Location: SPAIN , 15 years of age, After Clozapine was administered, patient had the following side effects: grand mal convulsion, myoclonus, speech disorder. During the same period patient was treated with CLOMIPRAMINE (View Clomipramine Review and Clomipramine Label ).

7020699-3 | Dilatation Ventricular, Dyskinesia, Epilepsy, Grand Mal Convulsion, Muscular Weakness, Myoclonus, Nervous System Disorder, Speech Disorder, Toxic Encephalopathy
on Sep 20, 2010 Male patient from SPAIN , 15 years of age, was diagnosed with obsessive-compulsive disorder (What is obsessive-compulsive disorder?), schizophrenia and was treated with Clozapine (View Usage). Patient experienced the following unwanted or unexpected effects: dilatation ventricular, dyskinesia, epilepsy (What is epilepsy?), grand mal convulsion, muscular weakness, myoclonus, nervous system disorder, speech disorder, toxic encephalopathy. Clozapine dosage: 350 Mg/day. During the same period patient was treated with CLOMIPRAMINE (225 Mg/day) (View Clomipramine Review and Clomipramine Label ), VITAMIN E (View Vitamin E Review and Vitamin E Label ).


7020682-8 | Hypomania, Irritability, Logorrhoea, Psychomotor Hyperactivity
on Sep 20, 2010 Male patient from TURKEY , 31 years of age, was diagnosed with schizophrenia and was treated with Clozapine (View Usage). Patient had the following side effects: hypomania, irritability, logorrhoea, psychomotor hyperactivity. Clozapine dosage: . During the same period patient was treated with MODAFINIL (View Modafinil Review and Modafinil Label ).

7020375-7 | Catatonia, Clonus, Gaze Palsy, Mental Status Changes, Restlessness, Suicide Attempt, Therapeutic Response Decreased, Withdrawal Syndrome
Patient was taking Clozapine (View Usage). After Clozapine was administered, patient had the following side effects: catatonia, clonus, gaze palsy, mental status changes, restlessness, suicide attempt, therapeutic response decreased, withdrawal syndrome on Sep 10, 2010 from UNITED STATES Additional patient health information: Female patient , 49 years of age, was diagnosed with schizophrenia, paranoid type and. Clozapine dosage: 550 Mg Daily Po. During the same period patient was treated with ESCITALOPRAM (View Escitalopram Review and Escitalopram Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ). Patient was hospitalized.

7019635-5 | Salivary Hypersecretion
Adverse event was reported on Sep 28, 2010 by a Female patient taking Clozapine (View Usage) (Dosage: 225 Mg Daily Po) . Location: UNITED STATES , 60 years of age, weighting 150.0 lb, Patient experienced the following unwanted or unexpected effects: salivary hypersecretion.

7019629-X | Drooling
on Sep 28, 2010 Female patient from UNITED STATES , 33 years of age, weighting 150.0 lb, was treated with Clozapine (View Usage). Patient had the following side effects: drooling. Clozapine dosage: 600 Mg Daily Po.

7019557-X | Neutropenia
on Sep 28, 2010 Male patient from UNITED STATES , 45 years of age, weighting 150.0 lb, was treated with Clozapine (View Usage). After Clozapine was administered, patient had the following side effects: neutropenia. Clozapine dosage: 50 Mg Daily Po.

7019288-6 | Cachexia, Coagulopathy, Colitis Ischaemic, Constipation, Delirium, Faecaloma, Haematemesis, Haemodynamic Instability, Hypotension
Patient was taking Clozapine (View Usage). Patient experienced the following unwanted or unexpected effects: cachexia, coagulopathy, colitis ischaemic, constipation (What is constipation?), delirium, faecaloma, haematemesis, haemodynamic instability, hypotension on Sep 08, 2010 from SPAIN Additional patient health information: Male patient , 34 years of age, was diagnosed with schizophrenia, paranoid type and. Clozapine dosage: 200 Mg/day Po. Patient was hospitalized.

7018935-2 | Catatonia
Adverse event was reported on Sep 14, 2010 by a Female patient taking Clozapine (View Usage) (Dosage: 250mg Qam) was diagnosed with schizophrenia, paranoid type and. Location: UNITED STATES , 49 years of age, Patient had the following side effects: catatonia. During the same period patient was treated with ESCITALOPRAM (View Escitalopram Review and Escitalopram Label ), TRAZODONE (200mg At Night) (View Trazodone Review and Trazodone Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ).

7018933-9 | Colitis Ischaemic
on Sep 14, 2010 Male patient from SPAIN , 34 years of age, was diagnosed with schizophrenia, paranoid type and was treated with Clozapine (View Usage). After Clozapine was administered, patient had the following side effects: colitis ischaemic. Clozapine dosage: Progressively Increased To A Maximum Dosage Of 200 Mg/day. Patient was hospitalized.

7015221-1 | Dysphagia, Oesophageal Achalasia, Oesophageal Hypomotility, Oesophageal Operation, Oesophagitis
on Sep 17, 2010 Male patient from UNITED KINGDOM , 36 years of age, was treated with Clozapine (View Usage). Patient experienced the following unwanted or unexpected effects: dysphagia, oesophageal achalasia, oesophageal hypomotility, oesophageal operation, oesophagitis. Clozapine dosage: Unk. During the same period patient was treated with ZAPONEX (400 Mg, Qd) (View Zaponex Review and Zaponex Label ).

7013765-X | Acromegaly, Decreased Appetite, Diabetes Mellitus, Erectile Dysfunction, Prognathism, Weight Decreased
Patient was taking Clozapine (View Usage). Patient had the following side effects: acromegaly, decreased appetite, diabetes mellitus, erectile dysfunction (What is erectile dysfunction?), prognathism, weight decreased on Aug 16, 2010 from SRI LANKA Additional patient health information: Male patient , 41 years of age, weighting 216.1 lb, was diagnosed with schizophrenia and. Clozapine dosage: 400 Mg Per Day. During the same period patient was treated with HYDROCHLOROTHIAZIDE (25 Mg Per Day) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LOSARTAN POTASSIUM (50 Mg, Bid) (View Losartan Potassium Review and Losartan Potassium Label ), NIFEDIPINE (20 Mg, Bid) (View Nifedipine Review and Nifedipine Label ).

7010863-1 | Myocarditis, Tachycardia
Adverse event was reported on Sep 23, 2010 by a Male patient taking Clozapine (View Usage) (Dosage: 125mg Am Po) was diagnosed with schizoaffective disorder and. Location: UNITED STATES , weighting 214.0 lb, After Clozapine was administered, patient had the following side effects: myocarditis, tachycardia.

7010220-8 | Catatonia, Clonus, Mental Status Changes, Pupil Fixed, Restlessness
on Sep 13, 2010 Female patient from UNITED STATES , 49 years of age, was diagnosed with schizophrenia, paranoid type and was treated with Clozapine (View Usage). Patient experienced the following unwanted or unexpected effects: catatonia, clonus, mental status changes, pupil fixed, restlessness. Clozapine dosage: 250 Mg, Qd. During the same period patient was treated with ESCITALOPRAM (40 Mg/day) (View Escitalopram Review and Escitalopram Label ), TRAZODONE HCL (200 Mg/night) (View Trazodone Hcl Review and Trazodone Hcl Label ), LAMOTRIGINE (100 Mg/day) (View Lamotrigine Review and Lamotrigine Label ). Patient was hospitalized.

7008082-8 | Gastrointestinal Hypomotility, Intestinal Dilatation
on Sep 08, 2010 Male patient from UNITED KINGDOM , 41 years of age, was treated with Clozapine (View Usage). Patient had the following side effects: gastrointestinal hypomotility, intestinal dilatation. Clozapine dosage: 650 Mg/day. During the same period patient was treated with AMITRIPTYLINE (NGX) (View Amitriptyline (ngx) Review and Amitriptyline (ngx) Label ), SERTRALINE (NGX) (View Sertraline (ngx) Review and Sertraline (ngx) Label ).

7008076-2 | Acute Hepatic Failure, Cardiomegaly, Gastrointestinal Hypomotility, Hepatic Necrosis, Intestinal Dilatation, Left Ventricular Hypertrophy, Liver Injury, Pulmonary Congestion, Pulmonary Oedema
Patient was taking Clozapine (View Usage). After Clozapine was administered, patient had the following side effects: acute hepatic failure, cardiomegaly, gastrointestinal hypomotility, hepatic necrosis, intestinal dilatation, left ventricular hypertrophy, liver injury, pulmonary congestion, pulmonary oedema on Sep 08, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 49 years of age, weighting 174.2 lb, . Clozapine dosage: 200 Mg/day. During the same period patient was treated with QUETIAPINE (View Quetiapine Review and Quetiapine Label ), ORPHENADRINE CITRATE (View Orphenadrine Citrate Review and Orphenadrine Citrate Label ).

7006585-3 | Neutrophil Count Decreased
Adverse event was reported on Sep 21, 2010 by a Male patient taking Clozapine (View Usage) (Dosage: Initiated At: 25 Mg Daily-hs Po) was diagnosed with schizoaffective disorder bipolar type and. Location: UNITED STATES , 33 years of age, weighting 121.7 lb, Patient experienced the following unwanted or unexpected effects: neutrophil count decreased. Patient was hospitalized.

6988216-1 | Neuroleptic Malignant Syndrome, Renal Failure Acute
on Sep 15, 2010 Male patient from GERMANY , 91 years of age, weighting 165.3 lb, was diagnosed with schizophrenia and was treated with Clozapine (View Usage). Patient had the following side effects: neuroleptic malignant syndrome, renal failure acute. Clozapine dosage: 1-0-1-3. During the same period patient was treated with PROMETHAZINE (100 Mg, Qid) (View Promethazine Review and Promethazine Label ), AMISULPRIDE (View Amisulpride Review and Amisulpride Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ). Patient was hospitalized.

6987498-X | Abdominal Pain Upper, Circulatory Collapse, Diarrhoea, Hepatic Necrosis, Hepatic Steatosis, Somnolence
on Sep 09, 2010 Female patient from UNITED KINGDOM , 37 years of age, was treated with Clozapine (View Usage). After Clozapine was administered, patient had the following side effects: abdominal pain upper, circulatory collapse, diarrhoea, hepatic necrosis, hepatic steatosis, somnolence. Clozapine dosage: 450 Mg, Qd. During the same period patient was treated with VENLAFAXINE (Unk) (View Venlafaxine Review and Venlafaxine Label ), DIHYDROCODEINE BITARTRATE INJ (View Dihydrocodeine Bitartrate Inj Review and Dihydrocodeine Bitartrate Inj Label ).

6987497-8 | Abdominal Distension, Arteriosclerosis Coronary Artery, Constipation, Hypertension, Left Ventricular Hypertrophy, Myocardial Ischaemia
Patient was taking Clozapine (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, arteriosclerosis coronary artery, constipation (What is constipation?), hypertension, left ventricular hypertrophy, myocardial ischaemia on Sep 09, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 47 years of age, weighting 215.0 lb, . Clozapine dosage: 625 Mg/d. During the same period patient was treated with AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), CODEINE (View Codeine Review and Codeine Label ), HYDROXYZINE (View Hydroxyzine Review and Hydroxyzine Label ).

6987496-6 | Pulmonary Congestion
Adverse event was reported on Sep 09, 2010 by a Female patient taking Clozapine (View Usage) (Dosage: 650 Mg/day) . Location: UNITED KINGDOM , 55 years of age, Patient had the following side effects: pulmonary congestion.

6987495-4 | Abdominal Distension, Gastric Dilatation, Pulmonary Congestion, Pulmonary Oedema
on Sep 09, 2010 Male patient from UNITED KINGDOM , 41 years of age, was treated with Clozapine (View Usage). After Clozapine was administered, patient had the following side effects: abdominal distension, gastric dilatation, pulmonary congestion, pulmonary oedema. Clozapine dosage: 650 Mg/day. During the same period patient was treated with AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), SERTRALINE HYDROCHLORIDE (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ).

6987493-0 | Aspiration, Choking
on Sep 09, 2010 Male patient from UNITED KINGDOM , 29 years of age, was treated with Clozapine (View Usage). Patient experienced the following unwanted or unexpected effects: aspiration, choking (What is choking?). Clozapine dosage: . During the same period patient was treated with CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ).

6987492-9 | Pulmonary Congestion
Patient was taking Clozapine (View Usage). Patient had the following side effects: pulmonary congestion on Sep 09, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 50 years of age, . Clozapine dosage: .

6987487-5 |
Adverse event was reported on Sep 09, 2010 by a Female patient taking Clozapine (View Usage) (Dosage: 600 Mg Per Day) . Location: UNITED KINGDOM , 40 years of age, .

6987483-8 | Constipation, Hypertension, Left Ventricular Hypertrophy, Pulmonary Oedema
on Sep 09, 2010 Male patient from UNITED KINGDOM , 48 years of age, was treated with Clozapine (View Usage). Patient experienced the following unwanted or unexpected effects: constipation (What is constipation?), hypertension, left ventricular hypertrophy, pulmonary oedema. Clozapine dosage: 850 Mg/day. During the same period patient was treated with LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ).

6987482-6 | Cardiac Arrest, Cardiomegaly, Duodenitis, Gastrointestinal Erosion, Intestinal Congestion, Pulmonary Congestion, Pulmonary Oedema
on Sep 09, 2010 Male patient from UNITED KINGDOM , 29 years of age, weighting 178.6 lb, was treated with Clozapine (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), cardiomegaly, duodenitis, gastrointestinal erosion, intestinal congestion, pulmonary congestion, pulmonary oedema. Clozapine dosage: . During the same period patient was treated with DULOXETINE (View Duloxetine Review and Duloxetine Label ), NALTREXONE (View Naltrexone Review and Naltrexone Label ).

6987481-4 | Abdominal Distension, Aspiration, Asthenia, Blood Amylase Increased, Blood Bicarbonate Decreased, Blood Lactic Acid Increased, Brain Oedema, C-reactive Protein Increased
Patient was taking Clozapine (View Usage). After Clozapine was administered, patient had the following side effects: abdominal distension, aspiration, asthenia, blood amylase increased, blood bicarbonate decreased, blood lactic acid increased, brain oedema, c-reactive protein increased on Sep 09, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 41 years of age, . Clozapine dosage: 750 Mg/d. During the same period patient was treated with LACTULOSE (View Lactulose Review and Lactulose Label ). Patient was hospitalized.

6987480-2 | Pulmonary Congestion
Adverse event was reported on Sep 09, 2010 by a Male patient taking Clozapine (View Usage) (Dosage: Unk) . Location: UNITED KINGDOM , 54 years of age, Patient experienced the following unwanted or unexpected effects: pulmonary congestion.

6987479-6 | Acute Hepatic Failure, Cardiomegaly, Hepatic Necrosis, Intestinal Dilatation, Left Ventricular Hypertrophy, Liver Injury, Pulmonary Congestion, Pulmonary Oedema
on Sep 09, 2010 Male patient from UNITED KINGDOM , 49 years of age, weighting 174.2 lb, was treated with Clozapine (View Usage). Patient had the following side effects: acute hepatic failure, cardiomegaly, hepatic necrosis, intestinal dilatation, left ventricular hypertrophy, liver injury, pulmonary congestion, pulmonary oedema. Clozapine dosage: 200 Mg/day. During the same period patient was treated with QUETIAPINE (View Quetiapine Review and Quetiapine Label ), ORPHENADRINE CITRATE (View Orphenadrine Citrate Review and Orphenadrine Citrate Label ).

6984530-4 | Fall, Tremor
on Sep 14, 2010 Female patient from UNITED STATES , 61 years of age, weighting 175.0 lb, was treated with Clozapine (View Usage). After Clozapine was administered, patient had the following side effects: fall (What is fall?), tremor. Clozapine dosage: 700mg Po. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ), MIRALAX (View Miralax Review and Miralax Label ), BENZTROPINE MESYLATE (View Benztropine Mesylate Review and Benztropine Mesylate Label ), DOCUSATE (View Docusate Review and Docusate Label ), NITROFURANTOIN (View Nitrofurantoin Review and Nitrofurantoin Label ), SAPHRIS (View Saphris Review and Saphris Label ).

6981037-5 | Abdominal Pain, Cachexia, Colitis Ischaemic, Constipation, Delirium, Diarrhoea Haemorrhagic, Faecaloma, Gastrointestinal Haemorrhage, Haematemesis
Patient was taking Clozapine (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), cachexia, colitis ischaemic, constipation (What is constipation?), delirium, diarrhoea haemorrhagic, faecaloma, gastrointestinal haemorrhage, haematemesis on Sep 06, 2010 from SPAIN Additional patient health information: Male patient , 34 years of age, was diagnosed with schizophrenia, paranoid type and. Clozapine dosage: Maximum Of 200 Mg/day. Patient was hospitalized.

6980784-9 | Acidosis, Acute Respiratory Distress Syndrome, Blood Glucose Increased, Caesarean Section, Heart Rate Increased, Hypotension, Incorrect Dose Administered
Adverse event was reported on Aug 25, 2010 by a Female patient taking Clozapine (View Usage) (Dosage: 10 G) . Location: SOUTH AFRICA , 16 years of age, Patient had the following side effects: acidosis, acute respiratory distress syndrome, blood glucose increased, caesarean section, heart rate increased, hypotension, incorrect dose administered. Patient was hospitalized.

6980149-X | Completed Suicide
on Sep 03, 2010 Male patient from UNITED STATES , 36 years of age, was treated with Clozapine (View Usage). After Clozapine was administered, patient had the following side effects: completed suicide. Clozapine dosage: .

6971667-9 | Aggression, Asphyxia, Emphysema, Fibrosis, Hepatic Steatosis, Hypertonia, Lipomatosis, Loss Of Consciousness
on Sep 03, 2010 Male patient from GERMANY , 33 years of age, was diagnosed with schizophrenia, paranoid type and was treated with Clozapine (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, asphyxia, emphysema, fibrosis, hepatic steatosis, hypertonia, lipomatosis, loss of consciousness. Clozapine dosage: Unk. During the same period patient was treated with CHLORPROTHIXENE (View Chlorprothixene Review and Chlorprothixene Label ). Patient was hospitalized.

6971519-4 | Anxiety, Emotional Distress, Paroxysmal Perceptual Alteration, Visual Impairment
Patient was taking Clozapine (View Usage). Patient had the following side effects: anxiety (What is anxiety?), emotional distress, paroxysmal perceptual alteration, visual impairment on Aug 27, 2010 from INDIA Additional patient health information: Male patient , 32 years of age, was diagnosed with schizophrenia, paranoid type and. Clozapine dosage: Up To 200 Mg, Per Day.

6964094-1 | Granulocytopenia, Leukopenia, Pneumonia Aspiration, Sepsis
Adverse event was reported on Aug 20, 2010 by a Male patient taking Clozapine (View Usage) (Dosage: ) . Location: UNITED STATES , 55 years of age, weighting 152.0 lb, After Clozapine was administered, patient had the following side effects: granulocytopenia, leukopenia, pneumonia aspiration, sepsis (What is sepsis?).

6962148-7 | Dyspnoea, Oedema Peripheral, Pain, Pruritus, Pyrexia, Rash Maculo-papular, Tremor, White Blood Cell Count Increased
on Sep 01, 2010 Female patient from UNITED STATES , weighting 174.0 lb, was diagnosed with psychotic disorder (What is psychotic disorder?), convulsion and was treated with Clozapine (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, oedema peripheral, pain (What is pain?), pruritus, pyrexia, rash maculo-papular, tremor, white blood cell count increased. Clozapine dosage: 25mg Twice Daily Po. During the same period patient was treated with CARBAMAZEPINE (400mg Twice Daily Po A Few Months) (View Carbamazepine Review and Carbamazepine Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ). Patient was hospitalized.

6955798-5 | Pancytopenia
on Aug 26, 2010 Male patient from UNITED STATES , 19 years of age, weighting 151.0 lb, was diagnosed with bipolar i disorder and was treated with Clozapine (View Usage). Patient had the following side effects: pancytopenia. Clozapine dosage: . Patient was hospitalized.

6945001-4 | Faecal Incontinence, Urinary Incontinence
Patient was taking Clozapine (View Usage). After Clozapine was administered, patient had the following side effects: faecal incontinence, urinary incontinence (What is urinary incontinence?) on Aug 16, 2010 from UNITED STATES Additional patient health information: Female patient , 62 years of age, . Clozapine dosage: 200 Mg.

6938720-7 | Aspiration, Completed Suicide, Overdose
Adverse event was reported on Aug 13, 2010 by a Female patient taking Clozapine (View Usage) (Dosage: ) . Location: UNITED STATES , 51 years of age, Patient experienced the following unwanted or unexpected effects: aspiration, completed suicide, overdose. During the same period patient was treated with PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), CYTOMEL (View Cytomel Review and Cytomel Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), DETROL (View Detrol Review and Detrol Label ), MELOXCAM (View Meloxcam Review and Meloxcam Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6938669-X | Blood Potassium Decreased, Blood Pressure Decreased, Brain Natriuretic Peptide Increased, Breath Sounds Abnormal, Cardiac Murmur, Cardiomyopathy, Dyspnoea, Haemoglobin Decreased, Heart Rate Increased
on Aug 10, 2010 Female patient from NETHERLANDS , 62 years of age, was treated with Clozapine (View Usage). Patient had the following side effects: blood potassium decreased, blood pressure decreased, brain natriuretic peptide increased, breath sounds abnormal, cardiac murmur, cardiomyopathy (What is cardiomyopathy?), dyspnoea, haemoglobin decreased, heart rate increased. Clozapine dosage: 250 Mg. During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ), TOLBUTAMIDE (View Tolbutamide Review and Tolbutamide Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), ANTI DIABETICS (View Anti Diabetics Review and Anti Diabetics Label ). Patient was hospitalized.

6937785-6 | Balance Disorder, Muscle Rigidity, Neuroleptic Malignant Syndrome, Pyrexia
on Aug 20, 2010 Male patient from UNITED STATES , 54 years of age, weighting 129.0 lb, was treated with Clozapine (View Usage). After Clozapine was administered, patient had the following side effects: balance disorder, muscle rigidity, neuroleptic malignant syndrome, pyrexia. Clozapine dosage: 100 Mg Bid. Patient was hospitalized.

6929588-3 | Granulocytopenia, Leukopenia
Patient was taking Clozapine (View Usage). Patient experienced the following unwanted or unexpected effects: granulocytopenia, leukopenia on Aug 04, 2010 from UNITED STATES Additional patient health information: Male patient , 55 years of age, . Clozapine dosage: .

6928963-0 | Agranulocytosis, Leukopenia, Sepsis
Adverse event was reported on Aug 10, 2010 by a Female patient taking Clozapine (View Usage) (Dosage: ) . Location: CANADA , 56 years of age, Patient had the following side effects: agranulocytosis, leukopenia, sepsis (What is sepsis?).

6925938-2 | Atrial Tachycardia, Haemodynamic Instability, Left Ventricular Dysfunction, Myopathy, Supraventricular Tachycardia
on Aug 11, 2010 Female patient from UNITED KINGDOM , 29 years of age, was diagnosed with schizophrenia, vomiting and was treated with Clozapine (View Usage). After Clozapine was administered, patient had the following side effects: atrial tachycardia, haemodynamic instability, left ventricular dysfunction, myopathy, supraventricular tachycardia. Clozapine dosage: 600 Mg, Unk. During the same period patient was treated with AMISULPRIDE (200 Mg, Unk) (View Amisulpride Review and Amisulpride Label ), CYCLIZINE (50 Mg, Unk) (View Cyclizine Review and Cyclizine Label ), LORAZEPAM (1 Mg, Unk) (View Lorazepam Review and Lorazepam Label ), AMIODARONE (View Amiodarone Review and Amiodarone Label ).

6925924-2 | Arteriosclerosis Coronary Artery, Bacterial Infection, Blood Creatine Phosphokinase Increased, Blood Potassium Decreased, Cardiac Failure, Cardiac Murmur, Dyspnoea, Eosinophilia
on Aug 10, 2010 Male patient from NETHERLANDS , 57 years of age, was treated with Clozapine (View Usage). Patient experienced the following unwanted or unexpected effects: arteriosclerosis coronary artery, bacterial infection (What is bacterial infection?), blood creatine phosphokinase increased, blood potassium decreased, cardiac failure, cardiac murmur, dyspnoea, eosinophilia. Clozapine dosage: Unk. During the same period patient was treated with THIORIDAZINE HCL (View Thioridazine Hcl Review and Thioridazine Hcl Label ). Patient was hospitalized.

6922961-9 | Granulocytopenia, Leukopenia
Patient was taking Clozapine (View Usage). Patient had the following side effects: granulocytopenia, leukopenia on Aug 04, 2010 from UNITED STATES Additional patient health information: Male patient , 55 years of age, . Clozapine dosage: .